D. Ionescu

Heidi Roberts, Don D. Sin, John Yee, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Cytologic features and diagnostic value of PeriView FLEX transbronchial needle aspiration targeting pulmonary nodules

Carlos F. Villamil, S. Lam, È. Beaudoin, 2020, Cancer cytopathology.

Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.

A. Churg, D. Ionescu, B. Sheffield, 2017, Human pathology.

Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC.

M. Tsao, N. Leighl, Q. Chu, 2018, Cancer treatment reviews.

A 75-year-old man with an asymptomatic pleural-based mass discovered on routine chest radiographs. Primary pleural thymoma.

T. Colby, K. Leslie, D. Ionescu, 2006, Archives of pathology & laboratory medicine.

Protein expression and gene amplification of epidermal growth factor receptor in thymomas

S. Dacic, D. Ionescu, M. Nola, 2005, Cancer.

Patterns of Allelic Loss of Synchronous Adenocarcinomas of the Lung

S. Dacic, S. Finkelstein, S. Yousem, 2005, The American journal of surgical pathology.

Classifying Pulmonary and Urinary High-grade Neuroendocrine Carcinoma by CK7 Immunohistochemistry

Carlos F. Villamil, G. Wang, P. Black, 2022, Applied immunohistochemistry & molecular morphology : AIMM.

Nonsmall Cell Lung Carcinoma With Neuroendocrine Differentiation—An Entity of No Clinical or Prognostic Significance

R. Wood‐Baker, A. Gown, S. Leung, 2007, The American journal of surgical pathology.

Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma—case series and literature review

M. Hayes, D. Ionescu, R. Ali, 2018, Virchows Archiv.

C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.

S. Yousem, S. Studer, K. McCurry, 2005, Transplant immunology.

EGFR Point of Care Clinical Testing using Idylla Platform Decreases Laboratory Turnaround Time in Advanced Stage Non-Small Cell Lung Cancer, as Compared to New Generation Sequencing

C. Hughesman, D. Ionescu, B. Melosky, 2021, Journal of Medical and Radiation Oncology.

Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas.

D. Ionescu, Cheryl Ho, Gang-ping Wang, 2021, Cancer treatment and research communications.

Comparability of laboratory-developed and commercial PD-L1 assays in non-small cell lung carcinoma.

Gang Wang, D. Ionescu, Cheryl Ho, 2020, Annals of diagnostic pathology.

Canadian Multicentre Project on Standardization of PD-L1 22C3 Immunohistochemistry Laboratory Developed Tests for Pembrolizumab Therapy in Non-Small Cell Lung Cancer.

M. Tsao, C. Cheung, H. Sekhon, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A prospective clinical utility study of the impact of the 21-gene recurrence score assay (Oncotype DX) in estrogen receptor positive (ER+) node negative (pN0) breast cancer in academic Canadian centers.

K. Gelmon, S. Peacock, C. Lohrisch, 2012 .

Management of EGFR-mutated non-small-cell lung cancer: practical implications from a clinical and pathology perspective.

A. Karsan, M. Tsao, S. Kamel‐Reid, 2017, Current oncology.

Pulmonary crystal-storing histiocytoma.

T. Colby, K. Leslie, D. Ionescu, 2009, Archives of pathology & laboratory medicine.

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer

S. Banerji, C. Couture, T. Stockley, 2022, Current oncology.

Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation.

D. Jukic, D. Ionescu, Muammar Arida, 2009, Archives of pathology & laboratory medicine.

Primary Pulmonary Synovial Sarcoma: A Case with Unique and Impressive Computed Tomography Findings

D. Ionescu, T. Tucker, G. Kraushaar, 2015 .

Pulmonary Meningothelial-like Nodules: A Genotypic Comparison With Meningiomas

B. Omalu, S. Finkelstein, S. Yousem, 2004, The American journal of surgical pathology.

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

Nhu Le, C Blake Gilks, N. Le, 2008, Human pathology.

BCL-2 Expression is Prognostic for Improved Survival in Non-small Cell Lung Cancer

R. Wood‐Baker, H. Masoudi, S. Leung, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Utility of SOX6 and DAB2 for the Diagnosis of Malignant Mesothelioma

A. Churg, D. Ionescu, J. Naso, 2021, American Journal of Surgical Pathology.

Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer

Steven J. M. Jones, A. Gown, E. Pleasance, 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Hsp27 Inhibition with OGX-427 Sensitizes Non–Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy

M. Gleave, A. Zoubeidi, L. Fazli, 2015, Molecular Cancer Therapeutics.

Standardizing biomarker testing for Canadian patients with advanced lung cancer.

M. Tsao, C. Couture, S. Kamel‐Reid, 2018, Current oncology.

Challenging the Paradigm: EGFR wild-type benefit from an EGFR inhibitor in NSCLC

M. Tsou, J. Yang, D. Ionescu, 2017 .

The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignancies

Steven J. M. Jones, E. Pleasance, M. Marra, 2022, The journal of pathology. Clinical research.

A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer

M. Tsao, F. Shepherd, T. Reiman, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

RESULTS 1 a : In Patients with NSCLC , is There Sufficient Evidence to Recommend That Histologic Subtype Should Influence the Choice of Systemic Therapy ?

M. Tsao, F. Shepherd, T. Reiman, 2011 .

Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples

Samuel Leung, Jefferson Terry, A. Gown, 2010, The American journal of surgical pathology.

Parvovirus B19 infection in the immunocompromised host.

D. Ionescu, M. Melhem, Anca V. Florea, 2007, Archives of pathology & laboratory medicine.

“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy

Chao Li, Gang Han, Marius Ilie, 2019, Modern Pathology.

Immunohistochemistry is a Reliable Screening Tool for Identification of ALK Rearrangement in Non–Small-Cell Lung Carcinoma and is Antibody Dependent

C. Couture, K. Craddock, D. Ionescu, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Case of ALK-Rearranged Combined Lung Adenocarcinoma and Neuroendocrine Carcinoma with Diffuse Bone Metastasis and Partial Response to Alectinib

D. Ionescu, T. Tucker, B. Melosky, 2022, Current oncology.

PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer.

S. Lam, T. Shaipanich, D. Ionescu, 2019, Lung cancer.

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.

S. Lam, D. Sin, A. Tremblay, 2017, The Lancet. Oncology.

Relationship of thyroid transcription factor 1 to EGFR status in non-small-cell lung cancer.

A. Karsan, I. Bosdet, D. Ionescu, 2014, Current oncology.

EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer.

M. Tsao, S. Kamel‐Reid, A. Magliocco, 2012, Current oncology.

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer.

A. Karsan, Y. Yatabe, M. Tsao, 2021, Lung cancer.

Epidermoid metaplasia of the cervix.

D. Dabbs, D. Ionescu, Deepak Mohan, 2004, Archives of pathology & laboratory medicine.

Canadian ALK (CALK): A pan-Canadian multicenter study to optimize and standardize ALK immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for ALK gene rearrangements.

A. Karsan, Y. Yatabe, M. Tsao, 2013 .

Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer

B. Blencowe, A. Iafrate, A. Karsan, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Automated PD-L1 Scoring for Non-Small Cell Lung Carcinoma Using Open-Source Software

Calum MacAulay, D. Ionescu, Gang-ping Wang, 2021, Pathology & Oncology Research.

Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.

S. Banerji, M. Tsao, H. Sekhon, 2019, Current oncology.

Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified.

D. Ionescu, J. Laskin, C Ho, 2015, Current oncology.

A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced disease.

A. Karsan, I. Bosdet, D. Ionescu, 2014, Lung cancer.

A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancer.

K. Gelmon, S. Peacock, C. Lohrisch, 2013, European journal of cancer.

Use of Programmed Death Ligand-1 (PD-L1) Staining to Separate Sarcomatoid Malignant Mesotheliomas From Benign Mesothelial Reactions.

A. Churg, D. Ionescu, F. Derakhshan, 2020, Archives of pathology & laboratory medicine.

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia

W. Cheung, D. Ionescu, N. Murray, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comprehensive assessment of PD-L1 immunohistochemistry on paired tissue and cytology specimens from non-small cell lung cancer.

M. Tsao, D. Ionescu, M. Orain, 2020, Lung cancer.

Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.

M. Tsao, R. Albadine, M. Vincent, 2018, Current oncology.

Recurrent Sarcoidosis in Lung Transplant Allografts: Granulomas Are of Recipient Origin

J. Hunt, S. Yousem, D. Ionescu, 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

C. Kollmannsberger, D. Ionescu, L. Hoang, 2020, Case Reports in Oncology.

The Cost‐Effectiveness of High‐Risk Lung Cancer Screening and Drivers of Program Efficiency

S. Lam, D. Sin, A. Tremblay, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

LBA1Establishment of a diagnostic algorithm for ROS1 testing in Canada

M. Tsao, C. Cheung, C. Couture, 2017 .

Using Laser Raman Spectroscopy to Reduce False Positives of Autofluorescence Bronchoscopies: A Pilot Study

Haishan Zeng, Stephen Lam, S. Lam, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study.

Ming-Sound Tsao, Kazuhiro Yasufuku, Christian Couture, 2015, Chest.

Endoscopic Doppler optical coherence tomography and autofluorescence imaging of peripheral pulmonary nodules and vasculature.

Pierre Lane, Calum MacAulay, Wei Zhang, 2015, Biomedical optics express.

A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia

S. Lam, A. Bild, D. Sin, 2016, Cancer Prevention Research.

Impact of the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology clinical practice guidelines for EGFR and ALK testing in lung cancer in Canada.

D. Ionescu, 2013, Current oncology.

Histological subtype is associated with PD-L1 expression and CD8+ T-cell infiltrates in triple-negative breast carcinoma.

G. Wang, D. Ionescu, Chen Zhou, 2022, Annals of diagnostic pathology.

Primary pulmonary synovial sarcoma: a case report with unique and impressive computed tomography findings.

D. Ionescu, T. Tucker, G. Kraushaar, 2015, Canadian respiratory journal.